公开(公告)号：EP2997029A1

公开(公告)日：2016-03-23

申请号：EP14798509.7

申请日：2014-05-13

申请人： Glaxosmithkline LLC

发明人： BLUM, Charles, A. ,  OALMANN, Christopher ,  SZCZEPANKIEWICZ, Bruce, G. ,  CALDWELL, Richard, Dana ,  CASAUBON, Rebecca ,  WHITE, Brian, H. ,  PERNI, Robert, B. ,  KOPPETSCH, Karsten ,  DISCH, Jeremy, S. ,  NG, Pui, Yee ,  FOX, Ryan, Michael

IPC分类号： C07D471/04

CPC分类号： C07D471/18 ,  A61K31/4995 ,  A61K31/506 ,  A61K31/551 ,  A61K45/06 ,  A61P17/10 ,  C07D487/04 ,  C07D513/18 ,  C07D519/00

摘要： The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

公开(公告)号：EP2997029B1

公开(公告)日：2019-01-09

申请号：EP14798509.7

申请日：2014-05-13

申请人： GlaxoSmithKline LLC

发明人： BLUM, Charles, A. ,  OALMANN, Christopher ,  SZCZEPANKIEWICZ, Bruce, G. ,  CALDWELL, Richard, Dana ,  CASAUBON, Rebecca ,  WHITE, Brian, H. ,  PERNI, Robert, B. ,  KOPPETSCH, Karsten ,  DISCH, Jeremy, S. ,  NG, Pui, Yee ,  FOX, Ryan, Michael

IPC分类号： C07D471/18 ,  A61K31/551 ,  A61P3/00